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Background: Colonization of the intestine with some microorganisms has been shown to have beneficial health
effects. The association of bacteria with its human host starts soon after birth; however in infants born prematurely
establishment of normal intestinal flora is interrupted with colonization with potential pathogenic organisms
Probiotic supplementation may therefore be beneficial to the health of preterm infants. As most probiotic
organisms are difficult to culture, confirmation of their colonization after supplementation is difficult. In this study,
rapid qPCR assays for detection of presence of probiotic species in the intestine by faecal sampling is described in
both preterm infant and adult participants.
Findings: Probiotic colonization was determined using qPCR directed at amplification of organisms present in the
ingested probiotic Streptococcus thermophilus, Bifidobacterium animalis subsp. lactis and B. longum subsp. infantis.
Overall, differential detection of probiotic strains in faeces were found between adult and preterm infants, with 50%
of infants continuing to shed at least two probiotic strains three weeks after probiotic ingestion had ceased.
Conclusions: This study demonstrated rapid assessment of the preterm infant gut for colonization with probiotic
strains using real-time PCR. This method would be of great importance in studies of probiotics in prevention of
diseases and adverse clinical outcomes.
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The intestinal micro biota contains a diverse range of
bacterial species [1]. The bacterial community has also
been shown to have a symbiotic relationship with their
human host and is beneficial to human health [2,3]. This
association starts soon after birth [4]. Bifidobacterium
species (B. spp), commonly found in the intestine of
healthy infants, may influence postnatal immune devel-
opment, including susceptibility to sepsis and allergic
diseases [5]. In preterm infants, the development of the
intestinal micro biome is affected by the neonatal inten-
sive care unit environment, with decreased microbial
diversity, including colonization with potential pathogens
and association with late-onset sepsis and necrotizing
enterocolitis [6,7]. Supplementation with appropriate* Correspondence: Sepehr.tabrizi@thewomens.org.au
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reproduction in any medium, provided the orprobiotic strains including B.spp may therefore be
beneficial to the health of preterm infants, subject to
confirmation of detection in fecal output and possible
colonization. However, probiotic organisms are mostly
fastidious anaerobes and difficult to culture using con-
ventional techniques, as well as difficult to speciate,
being closely related to other naturally occurring spe-
cies [8]. Rapid, sensitive, molecular tests can provide
a faster and more accurate method to confirm micro
biota colonization [9,10]. In this study, changes in de-
tection of in-vivo probiotic ingested organisms were
measured using quantitative real-time PCR directed to
specific detection of the three organisms present in
the formulation.
Following approval by the Royal Women’s Hospital
Human Research and Ethics Committees, 12 preterm in-
fants born below 32 weeks gestation, weighing less than
1500 g and seven healthy adult volunteers were recruited
to participate. Written informed consent for participation
in the study was obtained from participants or, in cases
of infants from their parent or guardian. The probiotictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 PCR primer and probes sequences utilized in the study
Sequence (5′-3′)a
Target Primer/probe Ref
B. animalis subsp. lactis F: GTGGAGACACGGTTTCCC [13]
R: CACACCACACAATCCAATAC [13]
P: FAM-TTCACAGGTGGTGCATGGTCGT BHQ1 This paper
B. longum subsp. infantis F: TTCCAGTTGATCGCATGGTC [12]
R: GGAAACCCCATCTCTGGGAT [12]
P: CY5-TCAAgCCCAggTAAggTTCTTCgC BHQ3 This paper
S. thermophilus F: TTATTTGAAAGGGGCAATTGCT [11] Modified
R: GTGAACTTTCCACTCTCACAC [11] Modified
P: CY5-ACTACAAGATGGACCTGCGT BHQ3 This paper
aNucleotide bases among the primers and probes that are underlined represent locked nucleic acid bases. F, forward primer; R, reverse primer; P, probe;
FAM, 6-carboxyfluorescein; Cy5, cyanine 5; BHQ, Black Hole Quencher.
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New York, USA) containing 2 × 108 Bifidobacterium
longum subsp. infantis, 2.3 × 108 B. animalis subsp. lactis
and 2.3 × 108 Streptococcus thermophilus per gram
was ingested by adult participants (15 g or 1010 organ-
isms) and 6 preterm infants (1.5 g or 109 organisms) for
seven days, while six control infants were fed routinely
with their mother’s expressed breast milk.
Specimens for assay were collected by rotating a flocked
swab in feces, and then rotated in 400 μL of phosphate
buffered saline (PBS). Fecal samples were collected
prior to and at completion of probiotic ingestion, then
weekly up to 4 weeks and stored at −80°C until analyzed.
Two hundred μl of cell suspensions were extracted using
MagNA Pure LC system (Roche Diagnostics, Branchburg,
NJ) with the associated DNA Isolation Kit I protocol. DNA
was eluted in a final volume of 100 μL of MagNA Pure
Elution Buffer (Roche Diagnostics). Extracted DNA was
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Figure 1 Percentage of samples positive at each sampling time for ea
Dophilus. A) Infant B) Adult participants.for detection of B. longum subsp. infantis, S. thermophilus
and B. lactis. These assays are not strain specific and
will only detect the respective species within the sam-
ple being tested.
Each qPCRs was performed using the Light Cycler 480
real-time instrument (Roche Diagnostics), with each re-
action comprised of a 20 μl volume, containing 1x Light
Cycler 480 probes master mix (Roche Diagnostics),
1.0 μM each previously published specie-specific primers
[11-13] (Table 1), 200 nM each probe (Table 1), and 5 μl
of DNA template. All qPCR reactions had the same cyc-
ling parameters of 95°C for 10 minutes followed by 50 cy-
cles of 95°C for 10 seconds and 60°C for 55 seconds. Data
for each sample were plotted as a derivative of fluorescence
versus temperature. All samples which yielded linear
increases in their fluorescence readings relative to the
negative control sample were considered positive. Strict
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of infants who ingested probiotics by Week 1 (Figure 1A).
None of the three probiotic species were detected in the
12 preterm infants’ feces at Week 0 and subsequently
none of the 6 control infants had the probiotic strains
detected. B. longum subsp. infantis continued to be
detected in 75% of the infants four weeks after probiotic
ingestion had ceased.
In the adult group, S. thermophilus was present before
and throughout the intervention in all participants, due
to presence of this organism in readily available cheese
and yoghurts. B. longum subsp. infantis was detected in
feces of all 7 adult participants at Week 1, but not four
weeks after probiotic ingestion had ceased, whereas
B. animalis subsp. lactis was detectable in up to 40% of
adults, 4 weeks post probiotic ingestion (Figure 1B).
It is important to test a pre-supplementation sample
to ensure the subject is not positive for the probiotic or-
ganisms prior to its administration, as it is possible for
gut micro biota to already contain the organism [14].
This study demonstrated rapid assessment using real-
time PCR of preterm infant gut for colonization of
ingested probiotic strains. This method would be a valu-
able tool in studies evaluating probiotics in prevention
of diseases and adverse clinical outcomes [15].
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